ABBOTT LABORATORIES Amortization of Intangible Assets in USD from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Abbott Laboratories quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2010 to Q3 2025.
  • Abbott Laboratories Amortization of Intangible Assets for the quarter ending September 30, 2025 was $420M, a 10.6% decline year-over-year.
  • Abbott Laboratories Amortization of Intangible Assets for the twelve months ending September 30, 2025 was $1.73B, a 8.92% decline year-over-year.
  • Abbott Laboratories annual Amortization of Intangible Assets for 2024 was $1.88B, a 4.48% decline from 2023.
  • Abbott Laboratories annual Amortization of Intangible Assets for 2023 was $1.97B, a 2.34% decline from 2022.
  • Abbott Laboratories annual Amortization of Intangible Assets for 2022 was $2.01B, a 1.66% decline from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)

ABBOTT LABORATORIES Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.73B $420M -$50M -10.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-29
Q2 2025 $1.78B $420M -$51M -10.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $1.83B $420M -$52M -11% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q4 2024 $1.88B $465M -$16M -3.33% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-21
Q3 2024 $1.89B $470M -$26M -5.24% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-29
Q2 2024 $1.92B $471M -$27M -5.42% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 $1.95B $472M -$19M -3.87% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 $1.97B $481M -$15M -3.02% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-21
Q3 2023 $1.98B $496M -$2M -0.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.98B $498M -$9M -1.78% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $1.99B $491M -$21M -4.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $2.01B $496M -$18M -3.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-21
Q3 2022 $2.03B $498M -$22M -4.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $2.05B $507M +$3M +0.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.05B $512M +$3M +0.59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.05B $514M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $520M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $504M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $509M -$52M -9.27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 $561M +$75M +15.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $486M -$98M -16.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 $584M +$62M +11.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $928M $522M +$378M +263% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $550M $121M -$22M -15.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $572M $140M -$11M -7.29% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $583M $145M -$6M -3.97% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $589M $144M -$12M -7.69% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $601M $143M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $151M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $151M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $156M -$18M -10.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q1 2014 $174M -$25M -12.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 $199M -$190M -48.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $389M -$2.49M -0.64% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $392M +$116M +42.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q1 2010 $275M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06

ABBOTT LABORATORIES Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.88B -$88M -4.48% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 $1.97B -$47M -2.34% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 $2.01B -$34M -1.66% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-21
2021 $2.05B -$85M -3.99% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $2.13B +$196M +10.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $1.94B -$242M -11.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $2.18B +$203M +10.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $1.98B +$1.43B +259% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $550M -$51M -8.49% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $601M -$29M -4.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $630M -$161M -20.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $791M -$628M -44.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $1.42B -$230M -13.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $1.65B +$232M +16.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
2010 $1.42B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.